Newsroom
Zhifei Attends 2023 World Lung Health Conference and Visits World Heal...
Zhifei Attends 2023 World Lung Health Conference and Visits World Health Organization
2023-12-27
From November 15th to 18th, the Union World Conference on Lung Health, the most prestigious academic conference in the field of global tuber...
see details 》
Zhifei and GSK reached strategic cooperation, adding a new blockbuster...
Zhifei and GSK reached strategic cooperation, adding a new blockbuster product
2023-10-12
On October 8, 2023, Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "Zhifei") and GlaxoSmithKline (GSK Biologica...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approva...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approval in Kenya
2022-12-23
On December 22, the Company's Recombinant COVID-19 Vaccine (CHO Cell) was approved for marketing by the Pharmacy and Poisons Board (PPB) of...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approval in Kenya2022-12-23
Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s International Strategic Layout2022-11-09
On November 8, 2022, the Recombinant COVID-19 Vaccine (CHO Cell) and the Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell) of An...
Zhifei’s Second-generation Recombinant COVID-19 Vaccine Starts International Clinical Trial2022-11-09
Source: Xinhua News Agency The launch ceremony of the international clinical trial of the Recombinant COVID-19 Omicron-Delta Variant Vaccin...
WHO Announces Updates to its Guidelines on Tests for the Diagnosis of TB Infection2022-10-08
On September 30, World Health Organization (WHO) published its updated consolidated guidelines on tuberculosis (TB) and the use of tests fo...
WHO announces updates on new TB antigen-based skin tests for the diagnosis of TB infection2022-09-30
From WHO Official WebsiteA Guideline Development Group was convened by World Health Organization (WHO) from 31 January to 3 February 2022 t...